Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis.
暂无分享,去创建一个
J. D. de Vries-Bouwstra | M. Whitfield | T. Huizinga | R. Toes | R. Simms | Peter van ’t Hof | H. Mei | O. Distler | F. Kurreeman | H. Draisma | H. Mikkers | J. DeGroot | L. Chadli | G. Cai | T. Messemaker | Michael E. Johnson | V. Goelela | N. Orzechowski | A. Dorjée | J. Aarbiou | M. Boonstra | S. Andersen
[1] Alex Kuo,et al. Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. , 2016, JCI insight.
[2] T. Sellers,et al. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β. LncRNA-HIT-MEDIATED TGF-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA. , 2016, The Journal of Biological Chemistry.
[3] J. Rinn,et al. "Cat's Cradling" the 3D Genome by the Act of LncRNA Transcription. , 2016, Molecular cell.
[4] Shinichi Sato,et al. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. , 2016, Journal of dermatological science.
[5] J. Taube,et al. To Control Site-Specific Skin Gene Expression, Autocrine Mimics Paracrine Canonical Wnt Signaling and Is Activated Ectopically in Skin Disease. , 2016, The American journal of pathology.
[6] Z. Huang,et al. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells , 2016, Cell Death and Disease.
[7] S. Arron,et al. Landscape of Long Noncoding RNAs in Psoriatic and Healthy Skin. , 2016, The Journal of investigative dermatology.
[8] A. Sanders,et al. Phosphoinositide-3-Kinase Enhancers, PIKEs: Their Biological Functions and Roles in Cancer. , 2016, Anticancer Research.
[9] Huaxi Xu,et al. The Long Noncoding RNA IFNG-AS1 Promotes T Helper Type 1 Cells Response in Patients with Hashimoto’s Thyroiditis , 2015, Scientific Reports.
[10] Jeffrey T. Chang,et al. Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis , 2015, Arthritis & rheumatology.
[11] T. Huizinga,et al. Immunogenetics of rheumatoid arthritis: Understanding functional implications. , 2015, Journal of autoimmunity.
[12] Daniel R. Caffrey,et al. Cutting Edge: A Natural Antisense Transcript, AS-IL1α, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1α , 2015, The Journal of Immunology.
[13] V. Villegas,et al. Neighboring Gene Regulation by Antisense Long Non-Coding RNAs , 2015, International journal of molecular sciences.
[14] Jaclyn N. Taroni,et al. Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts , 2015, PloS one.
[15] T. Sellers,et al. Long Non-coding RNAs (LncRNA) Regulated by Transforming Growth Factor (TGF) β , 2015, The Journal of Biological Chemistry.
[16] Derek W Wright,et al. Gateways to the FANTOM5 promoter level mammalian expression atlas , 2015, Genome Biology.
[17] Viktor Martyanov,et al. Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms , 2015, PLoS Comput. Biol..
[18] X. Corbella,et al. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. , 2014, Seminars in arthritis and rheumatism.
[19] P. Khavari,et al. ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes , 2014, Genes & development.
[20] Yoshihide Hayashizaki,et al. Interactive visualization and analysis of large-scale sequencing datasets using ZENBU , 2014, Nature Biotechnology.
[21] L. Joosten,et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. , 2014, The New England journal of medicine.
[22] Xiao‐Jing Wang,et al. CtBP1 over-expression in keratinocytes perturbs skin homeostasis , 2013, The Journal of investigative dermatology.
[23] L. Steinmetz,et al. Gene regulation by antisense transcription , 2013, Nature Reviews Genetics.
[24] J. McGrath,et al. Keratin 9 Is Required for the Structural Integrity and Terminal Differentiation of the Palmoplantar Epidermis , 2013, The Journal of investigative dermatology.
[25] T. Radstake,et al. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin , 2013, Annals of the rheumatic diseases.
[26] Andrea Rau,et al. Differential meta-analysis of RNA-seq data from multiple studies , 2013, BMC Bioinformatics.
[27] Howard Y. Chang,et al. Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.
[28] M. Nishizawa,et al. Stabilization of human interferon-α1 mRNA by its antisense RNA , 2012, Cellular and Molecular Life Sciences.
[29] David G. Knowles,et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.
[30] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[31] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[32] M. Whitfield,et al. Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. , 2012, The American journal of pathology.
[33] S. Pendergrass,et al. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies , 2012, The Journal of investigative dermatology.
[34] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[35] C. Boileau,et al. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells. , 2011, Arthritis and rheumatism.
[36] Ann Richmond,et al. Chemokines in health and disease. , 2011, Experimental cell research.
[37] Li Yang,et al. Genomewide characterization of non-polyadenylated RNAs , 2011, Genome Biology.
[38] Xiangyin Kong,et al. Evidence for OTUD-6B Participation in B Lymphocytes Cell Cycle after Cytokine Stimulation , 2011, PloS one.
[39] J. Cracowski,et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population , 2010, Annals of the rheumatic diseases.
[40] C. Wahlestedt,et al. Regulatory roles of natural antisense transcripts , 2009, Nature Reviews Molecular Cell Biology.
[41] Y. Daaka,et al. Arf GTPase-activating Protein AGAP2 Regulates Focal Adhesion Kinase Activity and Focal Adhesion Remodeling* , 2009, Journal of Biological Chemistry.
[42] L. Hummers,et al. Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma , 2009, The Journal of Rheumatology.
[43] Sarah A. Pendergrass,et al. Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin , 2008, PloS one.
[44] R. Lafyatis,et al. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor β , 2008, Annals of the rheumatic diseases.
[45] Howard Y. Chang,et al. A systems biology approach to anatomic diversity of skin. , 2008, The Journal of investigative dermatology.
[46] Yong Zhang,et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine , 2007, Nucleic Acids Res..
[47] M. Mayes,et al. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. , 2006, Arthritis and rheumatism.
[48] S. Batalov,et al. Antisense Transcription in the Mammalian Transcriptome , 2005, Science.
[49] David Botstein,et al. Systemic and cell type-specific gene expression patterns in scleroderma skin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Bombardieri,et al. Anti‐collagen antibodies in systemic sclerosis and in primary Raynaud's phenomenon , 1995, Clinical and experimental immunology.
[51] F. Bosch,et al. Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.
[52] O. Braun-falco,et al. Levels of type IV collagen and laminin fragments in serum from patients with progressive systemic sclerosis. , 1988, Journal of Rheumatology.
[53] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[54] I. Makałowska,et al. Biological functions of natural antisense transcripts. , 2016, Acta biochimica Polonica.
[55] R. Kurokawa,et al. Long Noncoding RNAs , 2015, Springer Japan.